Cargando…
High throughput drug profiling
High throughput screening has significantly contributed to advances in drug discovery. The great increase in the number of samples screened has been accompanied by increases in costs and in the data required for the investigated compounds. High throughput profiling addresses the issues of compound s...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562836/ https://www.ncbi.nlm.nih.gov/pubmed/18924690 http://dx.doi.org/10.1155/S1463924600000304 |
_version_ | 1782159763252969472 |
---|---|
author | Entzeroth, Michael Chapelain, Béatrice Guilbert, Jacques Hamon, Valérie |
author_facet | Entzeroth, Michael Chapelain, Béatrice Guilbert, Jacques Hamon, Valérie |
author_sort | Entzeroth, Michael |
collection | PubMed |
description | High throughput screening has significantly contributed to advances in drug discovery. The great increase in the number of samples screened has been accompanied by increases in costs and in the data required for the investigated compounds. High throughput profiling addresses the issues of compound selectivity and specificity. It combines conventional screening with data mining technologies to give a full set of data, enabling development candidates to be more fully compared. |
format | Text |
id | pubmed-2562836 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2000 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-25628362008-10-16 High throughput drug profiling Entzeroth, Michael Chapelain, Béatrice Guilbert, Jacques Hamon, Valérie J Autom Methods Manag Chem Research Article High throughput screening has significantly contributed to advances in drug discovery. The great increase in the number of samples screened has been accompanied by increases in costs and in the data required for the investigated compounds. High throughput profiling addresses the issues of compound selectivity and specificity. It combines conventional screening with data mining technologies to give a full set of data, enabling development candidates to be more fully compared. Hindawi Publishing Corporation 2000 /pmc/articles/PMC2562836/ /pubmed/18924690 http://dx.doi.org/10.1155/S1463924600000304 Text en Copyright © 2000 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Entzeroth, Michael Chapelain, Béatrice Guilbert, Jacques Hamon, Valérie High throughput drug profiling |
title | High throughput drug profiling |
title_full | High throughput drug profiling |
title_fullStr | High throughput drug profiling |
title_full_unstemmed | High throughput drug profiling |
title_short | High throughput drug profiling |
title_sort | high throughput drug profiling |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562836/ https://www.ncbi.nlm.nih.gov/pubmed/18924690 http://dx.doi.org/10.1155/S1463924600000304 |
work_keys_str_mv | AT entzerothmichael highthroughputdrugprofiling AT chapelainbeatrice highthroughputdrugprofiling AT guilbertjacques highthroughputdrugprofiling AT hamonvalerie highthroughputdrugprofiling |